Recommendations for Phase IV studies in the development of lipid-lowering drugs.
Gregg
R E
RE
Bristol-Myers Squibb, Princeton, New Jersey, USA.
D002784:Cholesterol / Q000097:blood; D017327:Clinical Trials, Phase IV as Topic / Q000592:standards*; D017277:Drug Approval; D015507:Drugs, Investigational; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008055:Lipids / Q000097:blood; D012449:Safety; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration
D015507:Drugs, Investigational; D000960:Hypolipidemic Agents; D008055:Lipids; D002784:Cholesterol